![Timothy Thompson Black](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Thompson Black
Amministratore Delegato presso
Strategic Income Management LLC
Profilo
Mr. Timothy T.
Black is a Chief Compliance Officer at Strategic Income Management LLC.
He is responsible for day to day operations and SEC compliance matters.
Mr. Black is a former partner of Integra Ventures, a Seattle based private equity firm.
Integra Ventures is a federally licensed Small Business Investment Company, and he was responsible for regulatory compliance and oversight management for the firm.
He is an attorney whose prior practice focused on corporate and securities matters, including issues relating to investment advisers and broker dealers.
Mr. Black holds a B.A. from Colorado College and a J.D., with honors, from Seattle University.
Posizioni attive di Timothy Thompson Black
| Società | Posizione | Inizio |
|---|---|---|
Strategic Income Management LLC
 Strategic Income Management LLC Investment ManagersFinance SiM is an active manager which focuses its investment management in high yield fixed income, and in the case of the Equity Fund, the equity securities of high yield issuers. The firm employs a GARP-oriented investment approach and constructs a core portfolio around long-term secular trends. SiM invests in out-of-favor sectors and non-traditional high-yield instruments. They also tend to manage a relatively concentrated portfolio, and invest in a higher percentage of small-cap names (issuers with $500 million or less in outstanding debt) than would an index driven manager. | Amministratore Delegato | 01/09/2015 |
Precedenti posizioni note di Timothy Thompson Black
| Società | Posizione | Fine |
|---|---|---|
PLx Pharma, Inc. /Old/
 PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology Develops formulations of non steroidal anti-inflammatory drugs | Direttore/Membro del Consiglio | - |
Integra Ventures
 Integra Ventures Investment ManagersFinance Integra Ventures seeks investment opportunities companies located in the United States. The firm targets companies operating in the fields of drug development, biotech, medical devices and healthcare services. It provides financing for seed, early, late, growth and recapitalizations with an investment size ranging from $500,000 to $3 million. It acts as both lead and co-investor. | Consigliere Generale | - |
Formazione di Timothy Thompson Black
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
PLx Pharma, Inc. /Old/
PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology Develops formulations of non steroidal anti-inflammatory drugs | Health Technology |
Integra Ventures
Integra Ventures Investment ManagersFinance Integra Ventures seeks investment opportunities companies located in the United States. The firm targets companies operating in the fields of drug development, biotech, medical devices and healthcare services. It provides financing for seed, early, late, growth and recapitalizations with an investment size ranging from $500,000 to $3 million. It acts as both lead and co-investor. | Finance |
The Colorado College
 The Colorado College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seattle University
 Seattle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strategic Income Management LLC
Strategic Income Management LLC Investment ManagersFinance SiM is an active manager which focuses its investment management in high yield fixed income, and in the case of the Equity Fund, the equity securities of high yield issuers. The firm employs a GARP-oriented investment approach and constructs a core portfolio around long-term secular trends. SiM invests in out-of-favor sectors and non-traditional high-yield instruments. They also tend to manage a relatively concentrated portfolio, and invest in a higher percentage of small-cap names (issuers with $500 million or less in outstanding debt) than would an index driven manager. | Finance |
